BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24481450)

  • 1. Control of glioma cell death and differentiation by PKM2-Oct4 interaction.
    Morfouace M; Lalier L; Oliver L; Cheray M; Pecqueur C; Cartron PF; Vallette FM
    Cell Death Dis; 2014 Jan; 5(1):e1036. PubMed ID: 24481450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein.
    Ikushima H; Todo T; Ino Y; Takahashi M; Saito N; Miyazawa K; Miyazono K
    J Biol Chem; 2011 Dec; 286(48):41434-41441. PubMed ID: 21987575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of spheroids formed by rat glioma stem cells and neural stem cells reveals differences in glucose metabolism and promising therapeutic applications.
    Morfouace M; Lalier L; Bahut M; Bonnamain V; Naveilhan P; Guette C; Oliver L; Gueguen N; Reynier P; Vallette FM
    J Biol Chem; 2012 Sep; 287(40):33664-74. PubMed ID: 22782899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCT4 is epigenetically regulated by DNA hypomethylation of promoter and exon in primary gliomas.
    Shi J; Shi W; Ni L; Xu X; Su X; Xia L; Xu F; Chen J; Zhu J
    Oncol Rep; 2013 Jul; 30(1):201-6. PubMed ID: 23670345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells.
    Kefas B; Comeau L; Erdle N; Montgomery E; Amos S; Purow B
    Neuro Oncol; 2010 Nov; 12(11):1102-12. PubMed ID: 20667897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.
    Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B
    Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma.
    Mukherjee J; Phillips JJ; Zheng S; Wiencke J; Ronen SM; Pieper RO
    PLoS One; 2013; 8(2):e57610. PubMed ID: 23451252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis.
    Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G; Wang K
    J Cell Physiol; 2019 Nov; 234(11):20816-20828. PubMed ID: 31012108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oct4 is expressed in human gliomas and promotes colony formation in glioma cells.
    Du Z; Jia D; Liu S; Wang F; Li G; Zhang Y; Cao X; Ling EA; Hao A
    Glia; 2009 May; 57(7):724-33. PubMed ID: 18985733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoGDIα suppresses self-renewal and tumorigenesis of glioma stem cells.
    Wu F; Hu P; Li D; Hu Y; Qi Y; Yin B; Jiang T; Yuan J; Han W; Peng X
    Oncotarget; 2016 Sep; 7(38):61619-61629. PubMed ID: 27557508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
    Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
    Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OCT4 is up-regulated by DNA hypomethylation of promoter in recurrent gliomas.
    Wu Y; Sun B; Shi W; Ni L; Chen J; Cai G; Shi J
    Neoplasma; 2016; 63(3):378-84. PubMed ID: 26925786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription.
    Lee J; Kim HK; Han YM; Kim J
    Int J Biochem Cell Biol; 2008; 40(5):1043-54. PubMed ID: 18191611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell markers in glioma progression and recurrence.
    Hattermann K; Flüh C; Engel D; Mehdorn HM; Synowitz M; Mentlein R; Held-Feindt J
    Int J Oncol; 2016 Nov; 49(5):1899-1910. PubMed ID: 27600094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.
    Kuo KK; Lee KT; Chen KK; Yang YH; Lin YC; Tsai MH; Wuputra K; Lee YL; Ku CC; Miyoshi H; Nakamura Y; Saito S; Wu CC; Chai CY; Eckner R; Steve Lin CL; Wang SS; Wu DC; Lin CS; Yokoyama KK
    Stem Cells; 2016 Nov; 34(11):2613-2624. PubMed ID: 27341307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells.
    Zhu P; Wang Y; He L; Huang G; Du Y; Zhang G; Yan X; Xia P; Ye B; Wang S; Hao L; Wu J; Fan Z
    J Clin Invest; 2015 Oct; 125(10):3795-808. PubMed ID: 26426078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: A new regulatory mechanism for cancer stem cell formation.
    Maiuthed A; Bhummaphan N; Luanpitpong S; Mutirangura A; Aporntewan C; Meeprasert A; Rungrotmongkol T; Rojanasakul Y; Chanvorachote P
    J Biol Chem; 2018 Aug; 293(35):13534-13552. PubMed ID: 29986880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule activation of metabolic enzyme pyruvate kinase muscle isozyme 2, PKM2, circumvents photoreceptor apoptosis.
    Wubben TJ; Pawar M; Weh E; Smith A; Sajjakulnukit P; Zhang L; Dai L; Hager H; Pai MP; Lyssiotis CA; Besirli CG
    Sci Rep; 2020 Feb; 10(1):2990. PubMed ID: 32076076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure.
    Guerra-Rebollo M; Garrido C; Sánchez-Cid L; Soler-Botija C; Meca-Cortés O; Rubio N; Blanco J
    Sci Rep; 2019 Jul; 9(1):9549. PubMed ID: 31267022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.